Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Revance Therapeutics Inc (NASDAQ:RVNC)

25.50
Delayed Data
As of Oct 20
 -0.35 / -1.35%
Today’s Change
12.35
Today|||52-Week Range
28.75
+23.19%
Year-to-Date
No recent news for Revance Therapeutics Inc.

Today’s Trading

Previous close25.85
Today’s open26.00
Day’s range25.05 - 26.00
Volume119,551
Average volume (3 months)174,481
Market cap$785.9M
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-5.30%
Earnings growth (this year)-12.32%
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales1,939.92
Price/Book4.13

Competitors

 Today’s
change
Today’s
% change
AMPHAmphastar Pharmaceut...+0.05+0.27%
RETAReata Pharmaceutical...+1.01+3.18%
ACRSAclaris Therapeutics...-0.54-2.03%
VSARVersartis Inc-0.10-3.64%
Data as of 3:59pm ET, 10/20/2017

Financials

Next reporting dateNovember 14, 2017
EPS forecast (this quarter)-$0.93
Annual revenue (last year)$300.0K
Annual profit (last year)-$89.3M
Net profit margin-29,756.67%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
L. Daniel Browne
Chief Operating Officer
Abhay Joshi
Corporate headquarters
Newark, California

Forecasts